IHH Healthcare's Turkey Unit May See Growth Despite Political Tensions -- Market Talk

Dow Jones

Mar 28, 2025

0222 GMT - IHH Healthcare's Turkish unit is likely to maintain its growth momentum despite political uncertainty there, Maybank Investment Bank analysts Nur Natasha Ariza and Yin Shao Yang say in a note. While accounting adjustments related to hyperinflation may weigh on reported earnings amid the Turkish lira's depreciation, core earnings should remain resilient, they say. The Acibadem unit benefits from foreign-currency-denominated medical tourism and steady private healthcare spending, they say. Contributing 30% of IHH's 2024 revenue, the Turkey business is projected to see 9% Ebitda growth in 2025, helped partly by stable in-patient volumes, they add. The analysts remain positive on Acibadem's non-lira income and IHH's other key segments. Maybank maintains a buy rating on IHH and keeps its target price at MYR7.97. Shares are unchanged at MYR6.91. (yingxian.wong@wsj.com)

(END) Dow Jones Newswires

March 27, 2025 22:22 ET (02:22 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2522561070"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2522561070\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2522561070?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-03-28 10:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2522561070","market":"hk","top_or_hot":-1,"title":"IHH Healthcare's Turkey Unit May See Growth Despite Political Tensions -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0222 GMT - IHH Healthcare's Turkish unit is likely to maintain its growth momentum despite political uncertainty there, Maybank Investment Bank analysts Nur Natasha Ariza and Yin Shao Yang say in a note. While accounting adjustments related to hyperinflation may weigh on reported earnings amid the Turkish lira's depreciation, core earnings should remain resilient, they say. The Acibadem unit benefits from foreign-currency-denominated medical tourism and steady private healthcare spending, they say. Contributing 30% of IHH's 2024 revenue, the Turkey business is projected to see 9% Ebitda growth in 2025, helped partly by stable in-patient volumes, they add. The analysts remain positive on Acibadem's non-lira income and IHH's other key segments. Maybank maintains a buy rating on IHH and keeps its target price at MYR7.97. Shares are unchanged at MYR6.91. (yingxian.wong@wsj.com) \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  March 27, 2025 22:22 ET (02:22 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>IHH Healthcare's Turkey Unit May See Growth Despite Political Tensions -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIHH Healthcare's Turkey Unit May See Growth Despite Political Tensions -- Market Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-03-28 10:22</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0222 GMT - IHH Healthcare's Turkish unit is likely to maintain its growth momentum despite political uncertainty there, Maybank Investment Bank analysts Nur Natasha Ariza and Yin Shao Yang say in a note. While accounting adjustments related to hyperinflation may weigh on reported earnings amid the Turkish lira's depreciation, core earnings should remain resilient, they say. The Acibadem unit benefits from foreign-currency-denominated medical tourism and steady private healthcare spending, they say. Contributing 30% of IHH's 2024 revenue, the Turkey business is projected to see 9% Ebitda growth in 2025, helped partly by stable in-patient volumes, they add. The analysts remain positive on Acibadem's non-lira income and IHH's other key segments. Maybank maintains a buy rating on IHH and keeps its target price at MYR7.97. Shares are unchanged at MYR6.91. (yingxian.wong@wsj.com) \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  March 27, 2025 22:22 ET (02:22 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"HCSG","symbol_name":"Healthcare Svcs Group Inc","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2522561070","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2522561070","pubTimestamp":1743128520,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"0222 GMT - IHH Healthcare's Turkish unit is likely to maintain its growth momentum despite political uncertainty there, Maybank Investment Bank analysts Nur Natasha Ariza and Yin Shao Yang say in a note. While accounting adjustments related to hyperinflation may weigh on reported earnings amid the Turkish lira's depreciation, core earnings should remain resilient, they say. The Acibadem unit benefits from foreign-currency-denominated medical tourism and steady private healthcare spending, they say. Contributing 30% of IHH's 2024 revenue, the Turkey business is projected to see 9% Ebitda growth in 2025, helped partly by stable in-patient volumes, they add. The analysts remain positive on Acibadem's non-lira income and IHH's other key segments. Maybank maintains a buy rating on IHH and keeps its target price at MYR7.97. Shares are unchanged at MYR6.91. ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"HCSG":"Healthcare Svcs Group Inc","Q0F.SI":"IHH医疗保健集团","BK4137":"综合支持服务","BK6511":"医疗保健服务概念","BK6092":"保健护理机构"},"translate_title":"尽管政治紧张，IHH Healthcare的土耳其部门仍可能实现增长——市场讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"Q0F.SI":0.9,"HCSG":1},"content_text":"0222 GMT - IHH Healthcare's Turkish unit is likely to maintain its growth momentum despite political uncertainty there, Maybank Investment Bank analysts Nur Natasha Ariza and Yin Shao Yang say in a note. While accounting adjustments related to hyperinflation may weigh on reported earnings amid the Turkish lira's depreciation, core earnings should remain resilient, they say. The Acibadem unit benefits from foreign-currency-denominated medical tourism and steady private healthcare spending, they say. Contributing 30% of IHH's 2024 revenue, the Turkey business is projected to see 9% Ebitda growth in 2025, helped partly by stable in-patient volumes, they add. The analysts remain positive on Acibadem's non-lira income and IHH's other key segments. Maybank maintains a buy rating on IHH and keeps its target price at MYR7.97. Shares are unchanged at MYR6.91. (yingxian.wong@wsj.com) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 27, 2025 22:22 ET (02:22 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}